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t is commonly estimated that at least 20-30% of schizophrenia patients fail to respond adequately to antipsychotic treatment1. We are yet to understand 
the exact mechanisms contributing to this treatment-resistance. Reduced white matter fractional anisotropy (FA) – a marker of disrupted microstructural 
integrity detected by diffusion tensor imaging (DTI), is a well-established finding in schizophrenia, particularly in frontal and temporal regions2. 
Existing studies have largely utilised a voxel-based morphometry (VBM) approach, which is prone to alignment and smoothing drawbacks. In order to 
overcome these, this study used tract-based spatial statistics (TBSS), a relatively new technique deploying non-linear registration projecting FA values onto 
a mean FA skeleton. 
This study pooled existing datasets of in- & outpatients 
meeting DSM-IV criteria for schizophrenia recruited into several studies 
at the Institute of Psychiatry, Psychology & Neuroscience, King’s 
College London (UK). Subjects, aged 18-60, were divided into 
treatment refractory (n=34) and non-refractory (n=44) groups; the 
former included subjects who had been registered at any time with a 
mandatory UK clozapine monitoring service up until autumn 2011, the 
latter included subjects who had not been registered with these. 
Subjects were matched according to age, gender, handedness, duration 
of illness, and intelligence (using NART and WAIS-III scores).
DTI acquisition 
sequence was identical to Kanaan et al. (2009)3, using a 1.5 T GE 
Signa LX system with actively shielded magnetic field gradients 
(maximum amplitude 40 mT/m). At each slice location, seven images 
were acquired with no diffusion gradient applied, together with 
diffusion-weighted images in 64 gradient directions uniformly 
distributed in space as per Jones et al. (2002)4.
Diffusion data were processed with 
ExploreDTI. DTI source data were corrected for eddy current 
distortions and head motion. B-matrix was subsequently reoriented per 
subject to improve accuracy of tensor orientation estimations. Diffusion 
tensor was estimated by applying a non-linear least squares approach, 
with FA calculated from the diffusion tensor. TBSS v1.2 was utilised to 
conduct the voxel-wise statistical analysis of FA data and compare 
groups. FA images from all subjects were registered to standard 
Montreal Neurological Institute (MNI) space using the non-linear 
registration tool in FSL (FNIRT). A voxel-wise average across all 
subjects was calculated to create a mean FA image, which was 
’skeletonised’. An FA threshold of 0.3 was applied to the skeleton, 
optimised to correspond to major fibre bundles, generating a mean FA 
skeleton, which formed a representation of the tract centres common 
to all subjects. Aligned FA maps were then projected onto the mean FA 
skeleton to facilitate voxel-wise cross-subject statistics. 
Whole-brain statistical analyses 
identifying group differences in the skeletonised voxel-wise diffusion 
metrics were performed using Randomise v.2.1 (FSL). Differences in FA 
were assessed between refractory and non-refractory patients. The 
analysis utilised the threshold-free cluster enhancement (TFCE), using 
a nonparametric permutation test, in which group membership was 
permuted 5000 permutations for each contrast in order to generate 
voxelwise p-values corrected for multiple testing (significant at p<0.05, 
familywise error corrected). Age and gender were de-meaned prior to 
analysis and used as covariates of no-interest within the voxel-based 
statistical analysis.
hilst approaching significance level, differences in FA / white matter 
integrity detected between treatment refractory and non-refractory groups 
following voxel-wise analysis were not significant (p=0.05). Further analysis 
of the results did not reveal any trend level differences in white matter 
integrity. Age, gender, handedness, duration of illness, and intelligence were 
controlled for in these analyses. 
o our knowledge, this is the first study investigating white matter 
differences between treatment-respondent and treatment-refractory 
schizophrenia patients using DTI/TBSS2. Our results suggest that white 
matter integrity does not differ significantly between these groups. Whilst 
some differences in brain structure have been associated with outcome in 
schizophrenia, there is a general lack of consistent neuroimaging correlates 
of treatment resistance5, supporting our lack of positive findings. 
A multitude of possible confounders are likely to contribute to this paucity, 
ranging from the limited sensitivity of contemporary neuroimaging methods 
to inconsistent definitions of treatment-resistance. A multi-dimensional 
classification of treatment-resistance, including factors such as lifetime 
antipsychotic doses, quality of life measures, and social/occupational 
functioning, is likely to provide a more accurate representation of this 
population and thereby enable a more distinct detection of treatment 
response correlates using neuroimaging methods. 
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